NeurologyLive® Friday 5 — December 6, 2024

Author(s):

Key Takeaways

Omaveloxolone shows a positive long-term safety profile as the first FDA-approved treatment for Friedreich ataxia, according to clinical insights.
The 2024 Restless Legs Syndrome guidelines have undergone significant changes, which clinicians need to be aware of for effective patient management.
The intersection of multiple sclerosis and domestic violence presents hidden challenges, necessitating innovative support for vulnerable patients.
Advancements in blood biomarkers for Alzheimer's disease facilitate earlier diagnosis and treatment, with ongoing development of clinical guidelines for integration.
Shared decision-making in NMOSD therapy selection involves considering clinical characteristics, safety, administration, and cost-effectiveness of FDA-approved treatments.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 6, 2024.

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Interdisciplinary Team Needed to Apply Machine Learning in Epilepsy Surgery: Lara Jehi, MD, MHCDS

The epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer detailed the steps and teamwork required to implement a machine learning that predicts seizure outcomes in epilepsy surgery. [WATCH TIME: 4 minutes]

2: Overviewing Personalized Exercise Strategies for Migraine Management From AHS Scottsdale 2024: Anna Pace, MD

The vice chair of the American Academy of Sleep Medicine’s Clinical Practice The assistant professor of neurology at the Icahn School of Medicine at Mount Sinai provided an overview of a session on exercise and migraine presented at the 2024 Scottsdale Headache Symposium. [WATCH TIME: 5 minutes]

3: A Mother’s Fight Against Infantile Spasms: The Power of Instinct and Community

This story highlights a mother’s journey through her daughter Addie's diagnosis of Tuberous Sclerosis Complex (TSC), emphasizing the critical need for early diagnosis, parental advocacy, and the strength of community support.

4: NeuroVoices: Martina Bebin, MD, MPA, on Critical Aspects of Infantile Spasms Awareness

In our latest Q&A for NeuroVoices, the professor of neurology at the University of Alabama at Birmingham Epilepsy Center commented on various topics related to infantile spasms amid Infantile Spasms Awareness Week.

5: Exploring Gaps in RLS Treatment Through New 2024 Guidelines: Andy Berkowski, MD, PhD

The vice chair of the American Academy of Sleep Medicine’s Clinical Practice Guidelines Task Force commented on some of the unanswered questions following the recently published guidelines for restless legs syndrome. [WATCH TIME: 3 minutes]